Topics

Companies Related to "Study of the Pharmacokinetics of Trappsol and Effects on Potential Biomarkers of Niemann-Pick C1 (NPC1)" [Most Relevant Company Matches] RSS

18:22 EST 12th November 2019 | BioPortfolio

Here are the most relevant search results for "Study of the Pharmacokinetics of Trappsol and Effects on Potential Biomarkers of Niemann-Pick C1 (NPC1)" found in our extensive corporate database of over 50,000 company records.

Showing "Study Pharmacokinetics Trappsol Effects Potential Biomarkers Niemann Pick" Companies 1–25 of 2,300+

Extremely Relevant

CTD Holdings, Inc.

CTD Holdings, Inc. is a clinical-stage biotechnology company that develops cyclodextrin-based products for the treatment of disease. The company’s Trappsol® Cyclo™, an orphan drug designated product in the United States and Europe, is used to treat Niemann-Pick Disease Type C, a rare and fatal genetic disease, on a compassionate use basis as well as in three ongoing formal clinical t...


Cyclo Therapeutics, Inc.

Cyclo Therapeutics, Inc. is a clinical-stage biotechnology company that develops cyclodextrin-based products for the treatment of disease. The company’s Trappsol® Cyclo™, an orphan drug designated product in the United States and Europe, is in three ongoing formal clinical trials for Niemann-Pick Disease Type C, a rare and fatal genetic disease, (Clinical Trials.gov NCT02939547, NCT0...

Relevant

Vivomicx

We identify: real biomarkers for drug efficacy to speed up your development process Using this, you can relate true molecular effects to disease activity and the value of your biomarkers We Validate: the pharmacological identity of your NME in complex tissues in vivo, before your drug enters clinical testing the expression of your new putative targets in patient materials your biomarkers...


Asteres Inc.

Asteres Inc. develops secure self-service kiosks for the storage and delivery of prescriptions and consumer products. Asteres’ premier product is ScriptCenter, the first prescription pick-up kiosk for retail, healthcare, and military pharmacies worldwide that allows patients to pick up and pay for their items even when the pharmacy is closed. For more...

CannaRabbit

CannaRabbit is a fully licensed and insured Colorado courier company specializing in safe, reliable and efficient transport of test samples, flower, MIP (marijuana infused products) and banking services. CannaRabbit operates within the State of Colorado and offers affordable, scheduled pick-up and delivery services to a wide variety of customers and transp...

NeuroPointDX

NeuroPointDX is the diagnostics division of Stemina Biomarker Discovery. Stemina is a biotechnology company based in Madison, WI and Cambridge, MA that has developed a robust and reproducible proprietary platform for identifying changes in metabolism (“biomarkers”) utilizing highly sensitive analytical equipment and its proprietary platform technology. ...

Cellumen, Inc.

Cellumen is a systems cell biology company that is focused on defining the functions of genes, coding and non-coding RNA's, proteins and other cellular constituents that regulate and perform the myriad of functions that define normal life and are related to specific disease processes as potential biomarkers and/or targets for drug discovery and patient profiling. Cellumen uses multiple High Conten...

Biolinq Incorporated

Biolinq is a digital health company developing a skin-applied, minimally-invasive electrochemical biosensor platform which analyzes biomarkers in the interstitial fluid to provide actionable health information. Given the platform potential of the technology and the unique ability to simultaneously measure multiple biomarkers, the company aims to develop a ...

Banyan Biomarkers, Inc.

Banyan Biomarkers is the leader in developing in vitro diagnostic products to address unmet clinical needs for the detection of traumatic brain injury. The Company is focused on developing a simple point-of-care blood test that will be used by physicians to detect the presence and severity of brain trauma and improve the medical management of head i...

Northfield Laboratories

Northfield Laboratories Inc. is a leader in developing an oxygen-carrying red blood cell substitute for the treatment of life-threatening blood loss, when an oxygen-carrying fluid is required and red blood cells are not available. Northfield’s product, PolyHeme®, is a human hemoglobin-based temporary oxygen-carrying red blood cell substitute. PolyHeme® simultaneously restores lost blood volum...

Amplion Inc.

Amplion publishes BiomarkerBase™ (http://www.biomarkerbase.com), the most complete database of biomarkers in clinical use and development. BiomarkerBase™ includes every biomarker used in and FDA-approved test or drug label, and thousands of biomarkers being used and developed in clinical trials. Many of the world’s leading diagnostics and bi...

ImmunArray

Co-located in Rehovot, Israel and Richmond, Va., ImmunArray is a privately funded molecular diagnostics company dedicated to the development of novel blood-based tests that support the diagnosis and management of complex acute and chronic immune and neurodegenerative diseases. The company designs and analyzes sets of biomarkers known to be linked to a part...

Innovative NeuroTechnologies, Inc

The sequencing of the first draft of the entire Human Genome in 2001 has been a monumental scientific achievement. However, simple knowledge of the DNA sequence does not necessarily elucidate the particular function of a gene or its corresponding products, such as the mRNA or protein. Thus, functional genomic and proteomic technologies are required to understand the functions of genes and its pr...

BioClin Therapeutics, Inc.

BioClin Therapeutics, Inc. is a privately-held clinical stage drug development company developing biologics to address medical conditions in areas of high unmet need. The company’s lead candidate is B-701, a potential first-in-class human monoclonal antibody targeting FGFR3 (fibroblast growth factor receptor 3). B-701 is currently being evaluated in t...

Neurobehavioral Research Inc

NRI specializes in using EEG, structural MRI and neuropsychological and behavioral assessment to study the effects of drugs and diseases on brain structure and function. NRI also works towards developing new technologies to support this endeavor.

Veravas, Inc.

Veravas is transforming laboratory medicine with technology that delivers superior test results, providing confidence to clinicians and patients that diagnoses are accurate. The company is rapidly driving the commercialization of proprietary sample preparation products and new diagnostic tests. Veravas’ nano magnetic particles can identify, remove, ...

Brain Injury Research Institute

The Brain Injury Research Institute is a center for the study of traumatic brain injuries and prevention, which is affiliated with the Blanchette Rockefeller Neuroscience Institute at West Virginia University. The purpose of the Institute is to study the short and long-term impact of brain injuries in order to better understand the impact of concussions, the development of chronic traumatic enceph...

Algomedix Inc.

Algomedix Inc., a biotech company located in Mill Creek WA, and San Diego, CA, is developing potential first-in-class non-opioid medicines for chronic and acute pain. The company’s patented TRPA1 modulators, which are small molecule, orally delivered compounds, are designed to provide effective pain relief without any potential for addiction or abuse....

Vivus

VIVUS, Inc. is a pharmaceutical company dedicated to the development and commercialization of next-generation therapeutic products addressing obesity and sexual health. Analysts speculate that the potential market for obesity ranges from $5 billion to $10 billion annually, and the indications targeted by VIVUS' sexual health products each represent a projected market greater than $1 billion annual...

Quintiles Scotland

Safety PharmacologyQuintiles has safety pharmacology services to identify the potential adverse pharmacological effects of new chemical entities prior to first administration to man. Regulatory Safety Pharmacology packages Haemodynamics/ECG studies Cardiac action potential in vitro QT prolongationIon channels (e.g. HERG) Discovery SupportQuintiles pharmacologists can provide support in defining th...

Neurodyn Cognition Inc.

NCI is a private Canadian biotech company developing Memogain, a patented prodrug of an approved treatment for Alzheimer’s disease, galantamine (Reminyl®). Memogain’s intranasal administration achieves higher dose levels, with significantly greater brain bioavailability, while avoiding the compliance impairing gastro-intestinal adverse effects...

Neurolief Ltd.

Neurolief develops proprietary digital health neuromodulation technology to treat neurological and neuropsychiatric disorders such as migraine and depression. The company’s devices either complement or provide an alternative to pharmaceutical therapies, which are often ineffective and are associated with potential short- and long-term adverse effects. ...

Society for Neuroscience

The Society for Neuroscience is a nonprofit membership organization of basic scientists and physicians who study the brain and nervous system. Recognizing the field's tremendous potential, the Society was formed in 1969. It has grown from 500 members to more than 37,500 and is the world's largest organization of scientists devoted to the study of the brain.The Society's primary goal is to promote ...

Annexon Biosciences

Annexon’s pipeline of novel therapies includes two clinical-stage product candidates, ANX005, a monoclonal antibody, and ANX007, a fragmented monoclonal antibody, as well as other compounds in preclinical development. ANX005 is currently in a Phase 1/2 study in patients with Guillain-Barre Syndrome (GBS). Annexon also plans to evaluate ANX005 in complement-mediated neurodegenerative disorder...

CEL-SCI Corporation CEL-SCI Corporation

CEL-SCI's work is focused on finding the best way to activate the immune system to fight cancer and infectious diseases. Its lead investigational immunotherapy, Multikine* (Leukocyte Interleukin, Injection), is currently being studied in a pivotal Phase 3 clinical trial as a potential neoadjuvant treatment for patients with squamous cell carcinoma of the h...


More From BioPortfolio on "Study of the Pharmacokinetics of Trappsol and Effects on Potential Biomarkers of Niemann-Pick C1 (NPC1)"

Quick Search

Corporate Database Quicklinks